WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential … WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 …
Cytokinetics - Wikipedia
WebNov 18, 2024 · Pay at Cytokinetics is significantly lower than some of its highest paying competitors, like Exelixis, KLA, and Gilead Sciences, which pay $108,978, $107,730, and $99,828, respectively. Based in South San Francisco, CA, Cytokinetics is a small health care company with only 130 employees and an annual revenue of $55.8M. WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled ... dus multifamily loans
Cytokinetics To Participate In The 22nd Annual Needham
WebMar 31, 2024 · – Senior Reporter, San Francisco Business Times . Mar 31, 2024 Updated ... Cytokinetics' stock was up $1.09 per share, or more than 3%, to $35.30 in Friday morning trading. WebProud to be a San Francisco Business Times Best Place to Work in 2024 and 2024, a Great Place to Work-Certified company in 2024 and a part of Fortune's Best Workplaces in the Bay Area in 2024 and ... Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. duron paint colors wheel